Background: Juvenile-onset Huntington’s disease (JHD) is defined by onset at the age of 20 or younger and represents approximately 5% of all HD cases. Patients with JHD present with a broad range of symptoms and signs that only overlap partially with adult-onset HD. A greater awareness and understanding of the presentation of JHD would improve the diagnosis and treatment of this condition. Objective: To undertake a systematic review of the literature relating to the clinical features at first presentation of JHD. Methods: We searched MEDLINE and EMBASE for all studies describing presenting features of JHD patients, performed quality control, and collated and analysed the data. Results: We screened 2917 records for eligibility, ...
Objective: To investigate the reasons for the diagnostic delay of juvenile Huntington's disease pati...
Huntington’s disease is degenerative and effects both cognitive and motor functioning, beginning in ...
Huntington disease (HD) is a neurodegenerative disease of genetic origin, fewer than 10% of patients...
Huntington disease is an autosomal dominant inherited brain disorder that typically becomes manifest...
Huntington’s disease (HD) is a well-recognized progressive neurodegenerative disorder that follows a...
The Special Issue “Juvenile Onset Huntington’s Disease” highlights the growing interest in understan...
Huntington\u27s Disease (HD) is an autosomal dominant neurodegenerative disorder with a progressive ...
Huntington disease (HD) is caused by a pathologic cytosine-adenine-guanine (CAG) trinucleotide repea...
Background Huntington’s disease is a rare, autosomal dominant neurodegenerative disease characterize...
The juvenile form of Huntington's disease (HD) is a rare disorder. There are no population-based est...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that typic...
Introduction: Huntington’s disease (HD) is a neurodegenerative disorder caused by CAG expansion repe...
Huntington’s disease is a neurodegenerative disease which is caused by dominantly inherited cytosine...
Juvenile Huntington’s disease (JHD) has an onset before 20 years of age, and is characterized by beh...
ABSTRACT We analyzed demographic, clinical and genetic characteristics of juvenile Huntington diseas...
Objective: To investigate the reasons for the diagnostic delay of juvenile Huntington's disease pati...
Huntington’s disease is degenerative and effects both cognitive and motor functioning, beginning in ...
Huntington disease (HD) is a neurodegenerative disease of genetic origin, fewer than 10% of patients...
Huntington disease is an autosomal dominant inherited brain disorder that typically becomes manifest...
Huntington’s disease (HD) is a well-recognized progressive neurodegenerative disorder that follows a...
The Special Issue “Juvenile Onset Huntington’s Disease” highlights the growing interest in understan...
Huntington\u27s Disease (HD) is an autosomal dominant neurodegenerative disorder with a progressive ...
Huntington disease (HD) is caused by a pathologic cytosine-adenine-guanine (CAG) trinucleotide repea...
Background Huntington’s disease is a rare, autosomal dominant neurodegenerative disease characterize...
The juvenile form of Huntington's disease (HD) is a rare disorder. There are no population-based est...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that typic...
Introduction: Huntington’s disease (HD) is a neurodegenerative disorder caused by CAG expansion repe...
Huntington’s disease is a neurodegenerative disease which is caused by dominantly inherited cytosine...
Juvenile Huntington’s disease (JHD) has an onset before 20 years of age, and is characterized by beh...
ABSTRACT We analyzed demographic, clinical and genetic characteristics of juvenile Huntington diseas...
Objective: To investigate the reasons for the diagnostic delay of juvenile Huntington's disease pati...
Huntington’s disease is degenerative and effects both cognitive and motor functioning, beginning in ...
Huntington disease (HD) is a neurodegenerative disease of genetic origin, fewer than 10% of patients...